Delivery Order SPE2DB20D3103-SPE2DB25FQ4V8
- Not listed
- The Defense Logistics Agency awarded a $1,457.94 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Heparin 25,000 Unit/250-1/2 Normal Saline 250mL on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Heparin 1,000 Unit/500 mL in normal saline solution, 500 mL vials, with a ceiling value of $1,464.60. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion by September 11, 2025, and will be fulfilled from the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,761.14 for Heparin 25,000 Unit/250 mL in D5W solution (250 mL units) on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,968.72 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Heparin 25,000 unit/250 ml in D5W solution (250 ml units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Heparin Sodium 5,000 Unit/0.5 mL injections with a ceiling value of $4,419.10. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order represents a child...
- The Defense Logistics Agency awarded a $497.97 delivery order contract to Amerisourcebergen Drug Corp for the supply of 10,000 unit/10mL vials of heparin. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 18, 2023 under the firm fixed price contract awarded on September 15, 2023. The Defense Logistics Agency utilizes indefinite delivery/indefinite quantity contracts to support the medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $1,953.89, is for the delivery of 25,000 unit/250 ML heparin solutions in 250 ML bags. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract, valued at up to $3,933.54, is a firm fixed price delivery order for 4,564,071,282 units of the pharmaceutical product Heparin 25,000 Unit/250 mL-D5W 250 mL. This award is part of a larger indefinite delivery contract (IDC) with a potential value of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,567,532,521 units of Heparin Sodium 5,000 unit/0.5 mL injections. The $1,126.59 contract has a completion date of March 12, 2025 and is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical to provide a comprehensive range of medical commodities to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $2,413.80 Firm Fixed Price Delivery Order is for the provision of 4,564,336,591 units of Heparin 2,000 unit/2 mL vials. This contract has no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ4V8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,371.36 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Heparin 10,000 Unit/10 mL vials. This competitively awarded, firm fixed-price contract is scheduled for completion by September 29, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was used in this award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare operations globally, enabling the contractor to deliver a broad range of pharmaceutical products, medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen Drug Corp's extensive portfolio of federal medical procurement contracts demonstrates its established capability as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/26/25 |